Advancing Pharmaceutical Processes and Tools for Improved Health Outcomes

Advancing Pharmaceutical Processes and Tools for Improved Health Outcomes

Tagelsir Mohamed Gasmelseid (International University of Africa, Sudan)
Release Date: April, 2016|Copyright: © 2016 |Pages: 388
DOI: 10.4018/978-1-5225-0248-7
ISBN13: 9781522502487|ISBN10: 1522502483|EISBN13: 9781522502494
Hardcover:
Available
$185.00
TOTAL SAVINGS: $185.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
E-Book:
(Multi-User License)
Available
$166.50
List Price: $185.00
10% Discount:-$18.50
TOTAL SAVINGS: $18.50
Benefits
  • Multi-user license (no added fee)
  • Immediate access after purchase
  • No DRM
  • ePub with PDF download
Hardcover +
E-Book:
(Multi-User License)
Available
$220.00
TOTAL SAVINGS: $220.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Multi-user license (no added fee)
  • Immediate access after purchase
  • No DRM
  • ePub with PDF download
OnDemand:
(Individual Chapters)
Available
$37.50
TOTAL SAVINGS: $37.50
Benefits
  • Purchase individual chapters from this book
  • Immediate PDF download after purchase or access through your personal library
Description & Coverage
Description:

There has been a growing concern for the improvement of pharmaceutical services provided by healthcare institutions. This concern is also shared by other stakeholders including patients, regulatory organizations, pharmaceutical companies, insurance companies, and research institutions.

Advancing Pharmaceutical Processes and Tools for Improved Health Outcomes presents research-based perspectives on the pharmaceutical industry in today’s digitally-fueled world. Focusing on technological innovations for pharmaceutical applications as well as current trends in the industry, this publication is ideally designed for use by pharmacists, medical professionals, administrators in the medical field, health insurance professionals, researchers, and graduate-level students.

Coverage:

The many academic areas covered in this publication include, but are not limited to:

  • Disease Identification
  • Information Quality
  • Open Access
  • Pharmaceutical Education
  • Pharmacoinformatics
  • Policy Planning
Reviews and Testimonials

Editor Tagelsir Mohamed Gasmelseid presents readers with a collection of academic essays and scholarly articles focused on disease identification; information quality, open access, and policy planning in the health care industry; pharmaceutical education, and pharmacoinformatics. The nine contributions that make up the main body of the text are devoted to policy planning to support technological innovation in the pharmaceutical industry, STRIPA and the potential usefulness of medical apps, how to identify rheumatic diseases by general physicians, and a wide variety of other related subjects. The editor is a faculty member of the International University of Africa in the Sudan.

– ProtoView Reviews
Table of Contents
Search this Book:
Reset
Editor/Author Biographies
Tagelsir Mohamed Gasmelseid holds BSc, MSc, postgraduate diploma, MPhil, and PhD degrees in information systems. He published some articles in referred journal and contributed to some international conferences. His research interests include multi-agent, mobile and context aware systems, agent oriented software engineering and simulation, service oriented architectures and the use of software agents in management and decision support systems for Hydroinformatics, electronic commerce, medical informatics and electronic government. He is affiliated as an associate professor, Information Systems, College of Computer Sciences and Information Technology, King Faisal University (Saudi Arabia).
Editorial Policy
In order to ensure the highest ethical practices are achieved for each book, IGI Global provides a full document of policies and guidelines that all editors, authors, and reviewers are expected to follow. View Full Editorial Policy
Peer Review Process
The peer review process is the driving force behind all IGI Global books and journals. All IGI Global reviewers maintain the highest ethical standards and each manuscript undergoes a rigorous double-blind peer review process, which is backed by our full membership to the Committee on Publication Ethics (COPE). The full publishing process and peer review are conducted within the IGI Global eEditorial Discovery® online submission system and on average takes 30 days. Learn More
Ethics & Malpractice
IGI Global affirms that ethical publication practices are critical to the successful development of knowledge. Therefore, it is the policy of IGI Global to maintain high ethical standards in all publications. These standards pertain to all books, journals, chapters, and articles accepted for publication. This is in accordance with standard scientific principles and IGI Global’s position as a source of scientific knowledge. Learn More
Archiving
All of IGI Global's content is archived via the CLOCKSS and LOCKSS initiative. Additionally, all IGI Global published content is available in IGI Global's InfoSci® platform.